Cargando…
NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer
BACKGROUND: Globally, non-small-cell lung cancer (NSCLC) is one of the most prevalent tumors. Various studies have investigated its etiology, but the molecular mechanism of NSCLC has not been elucidated. METHODS: The GSE19804, GSE118370, GSE19188, GSE27262, and GSE33532 microarray datasets were obta...
Autores principales: | Li, Xia, Zhang, Lianlian, Yi, Zhongquan, Zhou, Jing, Song, Wenchun, Zhao, Panwen, Wu, Jixiang, Song, Jianxiang, Ni, Qinggan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119754/ https://www.ncbi.nlm.nih.gov/pubmed/35600043 http://dx.doi.org/10.1155/2022/1161931 |
Ejemplares similares
-
Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer
por: Xu, Wenjie, et al.
Publicado: (2019) -
Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021) -
NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022) -
Identification of WD-Repeat Protein 72 as a Novel Prognostic Biomarker in Non-Small-Cell Lung Cancer
por: Shi, Guanglin, et al.
Publicado: (2023) -
ANP32E contributes to gastric cancer progression via NUF2 upregulation
por: Zhu, Xiaowen, et al.
Publicado: (2022)